Ruben Caballero - 25 Jun 2026 Form 4 Insider Report for Corvex, Inc. (MOVE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Jun 2026, 17:00:06 UTC
Prior SEC filing
12 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ruben Caballero by Mark R. Busch, attorney-in-fact

Key filing fact

Ruben Caballero filed Form 4 for Corvex, Inc. (MOVE) on 26 Jun 2026.

Key facts

  • This page summarizes Ruben Caballero's Form 4 filing for Corvex, Inc. (MOVE).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 Jun 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 12 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001784388 Primary reporting owner

Caballero Ruben

Relationship
Director
Address
C/O CROVEX, INC., 3401 NORTH FAIRFAX DRIVE, SUITE 3230, ARLINGTON
Signature
/s/ Ruben Caballero by Mark R. Busch, attorney-in-fact
Signature date
26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MOVE transaction

Common Stock

Options Exercise

Transaction value
Shares
+29,197
Change %
+331%
Price
$0.9200*
Shares after
38,017
Date
25 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MOVE transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value
Shares
-29,197
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,197
Exercise price
$0.9200
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend.

Footnote F2

This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .